Yung Zip Chemical Ind Co Ltd

Yung Zip Chemical Ind Co Ltd has a debt-to-equity ratio of 0.27 and a current ratio of 1.92, indicating moderate leverage and reasonable short-term liquidity. However, the company reported negative operating cash flow of -4,042,000 TWD and free cash flow of -67,436,000 TWD, suggesting cash flow constraints. The negative net income of -14,364,000 TWD and operating income of -19,825,000 TWD further highlight financial stress. The company's return on equity of -2.44% and return on assets of -1.55% are below typical industry benchmarks, indicating poor profitability and asset utilization. Gross profit of 94,570,000 TWD on revenue of 474,221,000 TWD suggests a gross margin of approximately 20%, which is relatively low for a pharmaceutical company. Yung Zip Chemical Ind Co Ltd's revenue is primarily concentrated in the domestic market and overseas markets such as the United States, Thailand, Indonesia, and the Philippines. However, the company does not disclose specific revenue percentages by segment or geography, making it difficult to assess exposure concentration. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The negative operating income and net income suggest a challenging operating environment, potentially due to competitive pressures or cost overruns. The company faces liquidity and profitability risks, as evidenced by negative operating and free cash flows. The risk assessment indicates medium liquidity risk and low dilution risk, but the key flag of negative net cash after subtracting total debt highlights a significant financial constraint. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be analyzed. The company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability metrics.